1% LIDOCAINE HCl Injection — Class I drug recall D-0391-2015
Terminated recall by Hospira Inc., reported 2015-02-25, distributed nationwide. Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached
| Recall number | D-0391-2015 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2014-10-16 |
| Classified | 2015-02-13 |
| Reported by FDA | 2015-02-25 |
| Terminated | 2015-12-29 |
| Distributed | Nationwide (US) |
| Quantity | 100,100 units |
| Reason classes | specification failure |
| NDC | 00409-4279-02 |
| Lot numbers | 40-316-DK |
| Expiration dates | 2016-04-01 |
Product
1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vial (Twenty-five (25) units per box/fifty (50) units per case, NDC 0409-4279-02, Hospira, Inc., Lake Forest, IL 60045
Reason for recall
Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0391-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-01. Not affiliated with or endorsed by FDA. Not medical or legal advice.